LCN2 and Hyperglycemia: It is pertinent to highlight that before LCN2 blockade with the antibody, at 18 weeks of age, all mice subjected to T2D induction exhibited hyperglycemia, insulin resistance, and glucose intolerance (Fig. 2e, f, h, j, and l).